The trading price of Sonnet BioTherapeutics Holdings Inc (NASDAQ:SONN) floating higher at last check on current market day and closing at $3.10, 47.62% higher than its previous close.
Traders who pay close attention to intraday price movement should know that it has been fluctuating between $2.93 and $4.85. In examining the 52-week price action we see that the stock hit a 52-week high of $18.72 and a 52-week low of $1.66. Over the past month, the stock has lost -15.99% in value.
Sonnet BioTherapeutics Holdings Inc, whose market valuation is $3.19 million at the time of this writing, is expected to release its quarterly earnings report in January. Investors’ optimism about the company’s current quarter earnings report is understandable.
On the technical side, indicators suggest SONN has a 50% Sell on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 100% Sell, while an average of long term indicators suggests that the stock is currently 100% Sell.
Here is the average analyst rating on the stock as represented by 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock should be considered as either strong buy or strong sell respectively. The number of analysts that have assigned SONN a recommendation rating is 2. Out of them, 0 rate it a Hold, while 2 recommend Buy, whereas 0 assign an Overweight rating. 0 analyst(s) have tagged Sonnet BioTherapeutics Holdings Inc (SONN) as Underweight, while 0 advise Sell. Analysts have rated the stock Buy, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares.
A quick review shows that SONN’s price is currently 13.06% off the SMA20 and -24.93% off the SMA50. The RSI metric on the 14-day chart is currently showing 49.27, and weekly volatility stands at 23.18%. When measured over the past 30 days, the indicator reaches 15.27%. Sonnet BioTherapeutics Holdings Inc (NASDAQ:SONN)’s beta value is currently sitting at 0.43, while the Average True Range indicator is currently displaying 0.68.
To see how Sonnet BioTherapeutics Holdings Inc stock has been performing today in comparison to its peers in the industry, here are the numbers: SONN stock’s performance was 47.62% at last check in today’s session, and -75.32% in the past year.
An evaluation of the daily trading volume of Sonnet BioTherapeutics Holdings Inc (NASDAQ:SONN) indicates that the 3-month average is 474.99K. However, this figure has increased over the past 10 days to an average of 0.2.
Currently, records show that 0.84 million of the company’s shares remain outstanding. The insiders hold 5.21% of outstanding shares, whereas institutions hold 0.05%. The stats also highlight that short interest as of 2024-11-15, stood at 35196.0 shares, resulting in a short ratio of 0.03 at that time. From this, we can conclude that short interest is 426.00 of the company’s total outstanding shares. It is noteworthy that short shares in November were up slightly from the previous month’s figure, which was 20844.0. However, since the stock’s price has seen -77.73% year-to-date, investors’ interest is likely to be reignited due to its potential to move even lower.
